1. ACP-AAFP Guideline for Treating Dementia Recommends Individual Assessment Followed by Treatment Based on Drug Profile. Currently, Evidence is Insufficient to Compare Dementia Drugs.
[A separate news release on the guideline will be released (Clinical Guidelines, p. 370)].
2. New Blood Tests and Standard Test to Diagnose TB Evaluated
New T-cell blood tests, with fast turn-around time, are recommended for diagnosis of latent tuberculosis (Article, p. 325). A study involving 389 adults with moderate to high clinical suspicion of active tuberculosis evaluated two T- cell assays and tuberculin skin testing individually and in combination with each other. Researchers found the ELISpot(plus) more sensitive than the ELISpot and tuberculin skin testing. Almost all patients with active tuberculosis had positive results on either tuberculin skin testing or ELISpot(plus). If both tests are negative, active tuberculosis is very unlikely to be the diagnosis.
An editorial writer discusses the issues of specificity and sensitivity raised by the combination tests and says the search for a rapid, accurate test must go on (Editorial, p. 398).
3. New Model for Predicting Breast Cancer Risk Includes Breast Density
Researchers developed a new risk-prediction model that uses breast density in addition to other, better known predictors of breast cancer risk (Article, p. 337). Breast density seemed to be a useful addition to the model, and low breast density was associated with a low breast cancer risk regardless of family history of breast cancer and other factors. However, like older models, the new risk-prediction model had only modest ability to discriminate between women who will develop breast cancer and those who will not. Although the model is easy to use, its accuracy needs further study before it can be recommended for routine clinical practice.